7655-72-3 Usage
Uses
Used in Pharmaceutical Industry:
3,5-Dichloro-2-(trifluoromethyl)pyridine is used as a chemical intermediate for the synthesis of various pharmaceuticals. Its unique structure and reactivity make it a valuable component in the development of new drugs with specific therapeutic properties.
Used in Agrochemical Industry:
In the agrochemical industry, 3,5-Dichloro-2-(trifluoromethyl)pyridine serves as an intermediate in the production of pesticides and other agrochemicals. Its incorporation into these compounds can enhance their effectiveness in controlling pests and diseases in agriculture.
Used in Material Science:
3,5-Dichloro-2-(trifluoromethyl)pyridine is used as a building block in the development of new materials and organic compounds. Its unique chemical properties allow for the creation of novel materials with specific characteristics, such as improved stability or reactivity, for various applications in material science.
Used in Organic Chemistry Research:
Due to its high reactivity, 3,5-Dichloro-2-(trifluoromethyl)pyridine is utilized in organic chemistry research to explore new reaction pathways and develop innovative synthetic methods. Its unique structure provides opportunities for the study of novel chemical transformations and the synthesis of complex organic compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 7655-72-3 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 7,6,5 and 5 respectively; the second part has 2 digits, 7 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 7655-72:
(6*7)+(5*6)+(4*5)+(3*5)+(2*7)+(1*2)=123
123 % 10 = 3
So 7655-72-3 is a valid CAS Registry Number.
InChI:InChI=1/C6H2Cl2F3N/c7-3-1-4(8)5(12-2-3)6(9,10)11/h1-2H
7655-72-3Relevant academic research and scientific papers
ALPHA-D-GALACTOSIDE INHIBITORS OF GALECTINS
-
, (2018/02/27)
The present invention relates to a compound of the general formula (1). The compound of formula (1) is suitable for use in a method for treating a disorder relating to the binding of a galectin, such as galectin-1 to a ligand in a mammal, such as a human. Furthermore, the present invention concerns a method for treatment of a disorder relating to the binding of a galectin, such as galectin-1 to a ligand in a mammal, such as a human.
Phosphovanadomolybdic acid catalyzed direct C-H trifluoromethylation of (hetero)arenes using NaSO2CF3 as the CF3 source and O2 as the terminal oxidant
Li, Chifeng,Suzuki, Kosuke,Yamaguchi, Kazuya,Mizuno, Noritaka
supporting information, p. 1417 - 1420 (2017/02/23)
A direct C-H trifluoromethylation of (hetero)arenes using NaSO2CF3 (Langlois' reagent) as the CF3 source and O2 as the terminal oxidant has been developed. In the presence of catalytic amounts of phosphovanadomolybdic acids, such as H6PV3Mo9O40, various kinds of substituted benzenes and heteroaromatic compounds could be converted into the corresponding trifluoromethylated products.
ALPHA-D-GALACTOSIDE INHIBITORS OF GALECTINS
-
, (2016/08/23)
The present invention relates to a compound of the general formula (1). wherein the pyranose ring is a-D-galactopyranose, A is selected from The compound of formula (1) is suitable for use in a method for treating a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human. Furthermore the present invention concerns compounds for use in a method of treatment of a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human.
